home / stock / prtc / prtc news

PRTC News and Press, PureTech Health plc From 03/24/22

Stock Information
Company Name: PureTech Health plc
Stock Symbol: PRTC
Market: NASDAQ
Website: puretechhealth.com
Menu
PRTC PRTC Quote PRTC Short PRTC News PRTC Articles PRTC Message Board
Get PRTC Alerts

News, Short Squeeze, Breakout and More Instantly...
PRTC - PureTech Appoints Sharon Barber-Lui to Board of Directors & Audit Committee

Seasoned life sciences expert brings further global portfolio management and financial expertise from 20 years at Merck & Co. Inc. to the PureTech board Ms. Barber-Lui will also become chair of the Audit Committee of the board PureTech Health plc (Nasdaq: PRT...
PRTC - PureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product Officer

Jon David brings deep expertise in building and launching engaging products to the Akili leadership team PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted that its Found...

PRTC - PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic

New Plenity patient prescriptions increased 3.5-fold within the first three weeks of the national media campaign launch Gelesis has projected $58 million in net revenue in this first full launch year 2022 PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“Pur...

PRTC - PureTech Founded Entity Akili Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022

Akili, the maker of EndeavorRx ® , the first-and-only FDA-cleared prescription video game treatment, joins the ranks of Canva, Microsoft, SpaceX, and more PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a ...
PRTC - PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning

Electroencephalography data (EEG) demonstrate enhancement of brain activity specific to attention function in children 8-12 with ADHD following AKL-T01 (EndeavorRx) treatment Data show correlation between targeted activity in the brain and objective improvements in attention f...

PRTC - PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted today that its Founded Entity, Akili Interactive (“Akili”), a leading digital medicine company developing cognitive t...

PRTC - PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that Bharatt Chowrira, Ph.D., J.D....
PRTC - PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms

Plenity is designed to help people feel satisfied with smaller portions so they can eat less and lose weight, while enjoying the foods they love Gelesis®, the maker of Plenity, began trading on the New York Stock Exchange earlier this month PureTech Health plc...

PRTC - PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

In addition to PureTech’s advanced Wholly Owned Pipeline, Founded Entities are an additional source of value and Akili is now set to join the growing list of publicly-traded Founded Entities for PureTech, which also include Karuna Therapeutics (Nasdaq: KRTX), Vor Biopharma (Nas...

PRTC - PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar

Proceeds from this transaction will be used to further support the national launch of Plenity Gelesis will begin trading on the New York Stock Exchange as “GLS” on Friday, January 14, 2022 and will ring the opening bell on Tuesday, January 18 PureTech...
Previous 10 Next 10